Overcoming Proteasome Inhibitor-Refractory Multiple Myeloma With Elotuzumab, Bortezomib, Nelfinavir, and Dexamethasone.

Erath, Alexandra

Overcoming Proteasome Inhibitor-Refractory Multiple Myeloma With Elotuzumab, Bortezomib, Nelfinavir, and Dexamethasone. [electronic resource] - World journal of oncology Feb 2020 - 33-36 p. digital

Publication Type: Case Reports; Journal Article

1920-454X

10.14740/wjon1241 doi